Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma
NCT07540702
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Melasma
Facial Melasma
Interventions
BIOLOGICAL:
Injectable Platelet-Rich Fibrin
DRUG:
Tranexamic acid 100 mg/mL (Kapron)
Sponsor
Kasr El Aini Hospital